1. Axonal injury-dependent induction of the peripheral benzodiazepine receptor in small-diameter adult rat primary sensory neurons.
- Author
-
Karchewski LA, Bloechlinger S, and Woolf CJ
- Subjects
- Animals, Autoradiography methods, Axotomy methods, Carrier Proteins genetics, Cell Count methods, Cell Size physiology, Glial Fibrillary Acidic Protein metabolism, Immunohistochemistry methods, In Situ Hybridization methods, Indoleacetic Acids metabolism, Isoquinolines pharmacokinetics, Male, Neuralgia metabolism, Neurons classification, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Receptors, GABA-A genetics, Sciatic Neuropathy metabolism, Sciatic Neuropathy physiopathology, Spinal Cord metabolism, Time Factors, Tritium pharmacokinetics, Axons metabolism, Carrier Proteins metabolism, Ganglia, Spinal cytology, Neurons metabolism, Receptors, GABA-A metabolism
- Abstract
The peripheral benzodiazepine receptor (PBR), a benzodiazepine but not gamma-aminobutyric acid-binding mitochondrial membrane protein, has roles in steroid production, energy metabolism, cell survival and growth. PBR expression in the nervous system has been reported in non-neuronal glial and immune cells. We now show expression of both PBR mRNA and protein, and the appearance of binding of a synthetic ligand, [(3)H]PK11195, in dorsal root ganglion (DRG) neurons following injury to the sciatic nerve. In naïve animals, PBR mRNA, protein expression and ligand binding are undetectable in the DRG. Three days after sciatic nerve transection, however, PBR mRNA begins to be expressed in injured neurons, and 4 weeks after the injury, expression and ligand binding are present in 35% of L4 DRG neurons. PBR ligand binding also appears after injury in the superficial dorsal horn of the spinal cord. The PBR expression in the DRG is restricted to small and medium-sized neurons and returns to naïve levels if the injured peripheral axons are allowed to regrow and reinnervate targets. No non-neuronal PBR expression is detected, unlike its putative endogenous ligand the diazepam binding inhibitor (DBI), which is expressed only in non-neuronal cells, including the satellite cells that surround DRG neurons. DBI expression does not change with sciatic nerve transection. PBR acting on small-calibre neurons could play a role in the adaptive survival and growth responses of these cells to injury of their axons.
- Published
- 2004
- Full Text
- View/download PDF